Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $135.7100 (-0.47%) ($134.7600 - $136.7200) on Mon. Aug. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.34% (three month average) | RSI | 36 | Latest Price | $135.7100(-0.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.7% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(33%) DIA(27%) SPLV(25%) XLP(25%) VYM(24%) | Factors Impacting ABBV price | ABBV will decline at least -0.67% in a week (0% probabilities). VIXM(-16%) UUP(-14%) TBT(-3%) UNG(-2%) VXX(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.67% (StdDev 1.34%) | Hourly BBV | -1.1 () | Intraday Trend | -0.4% | | | |
|
Resistance Level | $140.09 | 5 Day Moving Average | $137.66(-1.42%) | 10 Day Moving Average | $139.45(-2.68%) | 20 Day Moving Average | $140.09(-3.13%) | To recent high | -12% | To recent low | 0% | Market Cap | $239.431b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |